author-photo

Margit Schmeidl

Medical University of Vienna

3

Papers

6

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC:

2020 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment

2019 Translational Oncology
Show All
- Source
- Cite
- Save
Citations (3)